Jelonia Rumph

Jelonia Rumph
Emory University | EU · Rollins School of Public Health

Doctor of Philosophy

About

14
Publications
1,388
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
146
Citations
Introduction
I am a Microbiology/Immunology PhD student at Meharry Medical College. My dissertation project focuses on the transgenerational and multigenerational effects of in utero dioxin exposure. My overall research interest is to understand how environmental toxicant exposure causes disease via the disruption of the immune and endocrine systems. I am also interested on reversing the effects of toxicant exposure through nutritional supplements.

Publications

Publications (14)
Article
Full-text available
Background: The most recent vitamin D data from the National Health and Nutrition Examination Survey (NHANES) have not been examined. We used data from NHANES to describe trends in 25-hydroxyvitamin D [25(OH)D] from 2011 to 2018 and for the most recent cycle (2017–2018) to identify groups with lower levels of 25(OH)D and factors predictive of 25(OH...
Article
Background Prostate cancer (PCa) is the second‐leading cause of cancer mortalities in the United States and is the most commonly diagnosed malignancy in men. While androgen deprivation therapy (ADT) is the first‐line treatment option to initial responses, most PCa patients invariably develop castration‐resistant PCa (CRPC). Therefore, novel and eff...
Article
Full-text available
New bronchopulmonary dysplasia (BPD) is a neonatal disease that is theorized to begin in utero and manifests as reduced alveolarization due to inflammation of the lung. Risk factors for new BPD in human infants include intrauterine growth restriction (IUGR), premature birth (PTB) and formula feeding. Using a mouse model, our group recently reported...
Article
Full-text available
Epidemiology and animal studies suggest that a paternal history of toxicant exposure contributes to the developmental origins of health and disease. Using a mouse model, our laboratory previously reported that a paternal history of in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increased his offspring’s risk of developing necrotizi...
Article
Full-text available
The detection of early-stage cancer offers patients the best chance of treatment and could help reduce cancer mortality rates. However, cancer cells or biomarkers are present in extremely small amounts in the early stages of cancer, requiring high-precision quantitative approaches with high sensitivity for accurate detection. With the advantages of...
Article
Full-text available
Women with endometriosis, the growth of endometrial glands and stroma outside the uterus, commonly also exhibit adenomyosis, the growth of endometrial tissues within the uterine muscle. Each disease is associated with functional alterations in the eutopic endometrium frequently leading to pain, reduced fertility, and an increased risk of adverse pr...
Article
Full-text available
Over the years, industrial accidents and military actions have led to unintentional, large-scale, high-dose human exposure to environmental contaminants with endocrine-disrupting action. These historical events, in addition to laboratory studies, suggest that exposure to toxicants such as dioxins and polychlorinated biphenyls negatively impact the...
Article
Full-text available
New bronchopulmonary dysplasia is a developmental lung disease associated with placental dysfunction and impaired alveolarization. Risk factors for new BPD include prematurity, delayed postnatal growth, the dysregulation of epithelial-to-mesenchymal transition (EMT), and parental exposure to toxicants. Our group previously reported that a history o...
Article
Full-text available
Advances in understanding disease pathogenesis correlates to modifications in gene expression within different tissues and organ systems. In depth knowledge about the dysregulation of gene expression profiles is fundamental to fully uncover mechanisms in disease development and changes in host homeostasis. The body of knowledge surrounding mammalia...
Chapter
Full-text available
As a consequence of industrialization, thousands of man-made chemicals have been developed with few undergoing rigorous safety assessment prior to commercial use. Ubiquitous exposure to these compounds, many of which act as endocrine-disrupting chemicals (EDCs), has been suggested to be one factor in the increasing incidence of numerous diseases, i...
Article
Background: Necrotizing enterocolitis (NEC) is a rare, but potentially fatal intestinal inflammatory condition most often arising in premature infants. Infants provided formula are also at greater risk of developing this disease. Although the majority of formula-fed, preterm infants do not develop NEC, up to 30% of infants with the disease do not...

Questions

Questions (4)
Question
Hello,
Has anyone ever performed an ELISA using murine stomach content samples? I collected stomach contents by removing the "pellet" from the stomach of neonatal mice and freezing it at -80. However, I am having trouble determining how to prepare these samples for ELISA. Any suggestions?
Question
I have not done an ELISA yet, but I am trying to prepare for one. Once I dilute serum using the general diluent, can I use the diluted samples for a different ELISA kit or do I need to dilute new samples?
EX: I diluted serum for an IL-6 ELISA, but in the future I want to run IL-1b ELISA...can I use the same diluted sample?
Question
Hello,
I am currently doing an exploratory study which requires me to section and stain lungs of mice, however this is new territory for me. This is a representative image of how my staining currently looks. Should this be considered artifacts from improper preservation or sectioning? Or is this indicative of dysplasia and lung inflammation?
After the necropsy, I place the lungs in 10% formalin and they are embedded between one day to one week from the necropsy date.
Question
Hello,
I recently performed rtPCR for PR A/B in the colon. However, at the end of the experiment, I saw there were two melting peaks. Does a primer for PR A/B normally produce two melting peaks? Or is it possible that my samples are contaminated?
Note: I performed rtPCR with the same samples for TLR4 and IL-8 and there was only one melting peak for each primer. I have tried the current rtPCR twice; once using Sybergreen and once using evagreen. However, regardless of the buffer I use, I get two melting peaks. Also, each of my reaction volumes are 10uL.

Network

Cited By